FIELD: medicine.
SUBSTANCE: invention refers to general anaesthetic based on 3-aminomethylenindolinon-2, taken in effective proportion to prevent by-effects and thereby surpassing present-day noninhalation anaesthetics. Method of 3-aminomethylenindolinon-2 production is described.
EFFECT: do not have significant by-effects and thereby surpasses present-day noninhalation anaesthetics.
5 tbl, 2 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 1-METHYL-3,4-(DELTA 2,2-DIMETHYL-4-OXOTETRAHYDROBENZO)-TRANQUILIZING ACTIVITY | 0 |
|
SU753093A1 |
| 0 |
|
SU1781221A1 | |
| METHOD OF NONINHALATION ANESTHESIA IN EXPERIMENT ON ANIMALS | 1992 |
|
RU2072872C1 |
| METHOD FOR COMBINED GENERAL ANESTHESIA IN ONCOLOGICAL PATIENTS | 2001 |
|
RU2211696C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTICONVULSANT ACTIVITY FOR PARENTERAL INTRODUCTION | 2011 |
|
RU2463052C1 |
| METHOD FOR PREVENTING COMPLICATIONS INDUCED BY NON- INHALATION TYPE ANESTHESIA | 1992 |
|
RU2043125C1 |
| METHOD OF COMBINED GENERAL ANAESTHESIA IN ONCOLOGICAL PATIENTS | 2010 |
|
RU2479324C2 |
| METHOD FOR MAINTAINING ANESTHETIC SUPPORT IN PERFORMING NEUROORTHOPEDIC LOW INVASIVE OPERATIONS | 2000 |
|
RU2193405C2 |
| METHOD TO CONDUCT INTRAVENOUS GENERAL ANESTHETIZATION | 1995 |
|
RU2112558C1 |
| 3-BENZYLAMINOMETHYLENEPYRROLIDINE-2,4-DIONE AND ANTICONVULSANT AGENT BASED ON SAID | 1997 |
|
RU2144918C1 |
